Biochemical factors of hypoxia and their role in assessing the functional state of the fetus
- Authors: Rozhdestvenskaya O.V.1, Kokaya A.A.2,3, Bezhenar V.F.1
-
Affiliations:
- Academician I.P. Pavlov First St. Petersburg State Medical University
- Maternity Hospital No. 16
- State Research Institute of Applied Problems
- Issue: Vol 70, No 6 (2021)
- Pages: 117-126
- Section: Reviews
- URL: https://journals.rcsi.science/jowd/article/view/71300
- DOI: https://doi.org/10.17816/JOWD71300
- ID: 71300
Cite item
Abstract
The constant frequent incidents of fetal hypoxia during pregnancy and childbirth remain the leading unsolved problem in modern practical obstetrics. In some cases, the onset of a pathological process can be diagnosed earlier due to the on-time monitoring of functional disorders of the fetus. However, the existing diagnostic methods do not show the compensatory and adaptive capabilities of the fetus; do not lead to an in-depth understanding of the pathophysiology of this condition and do not contribute to the implementation of evidence-based therapy. This review summarizes current knowledge about the diagnosis of functional disorders of the fetus and discusses possible ways of assessing adaptive mechanisms in response to stress during pregnancy and childbirth. The article shows the development of biochemical methods for diagnosing functional disorders of the fetus. The putative biochemical markers for assessing the compensatory capabilities of the fetus during pregnancy and childbirth are presented.
Full Text
##article.viewOnOriginalSite##About the authors
Olga V. Rozhdestvenskaya
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: olgamish@inbox.ru
ORCID iD: 0000-0003-2280-9196
Russian Federation, Saint Petersburg
Anna A. Kokaya
Maternity Hospital No. 16; State Research Institute of Applied Problems
Email: kann9998@yandex.ru
ORCID iD: 0000-0001-7324-5947
MD, Cand. Sci. (Med.)
Russian Federation, Saint PetersburgVitaly F. Bezhenar
Academician I.P. Pavlov First St. Petersburg State Medical University
Author for correspondence.
Email: vitaliy@yandex.ru
ORCID iD: 0000-0002-7807-4929
SPIN-code: 8626-7555
Scopus Author ID: 57191963583
ResearcherId: R-7055-2017
MD, Dr. Sci. (Med.), Professor
Russian Federation, Saint PetersburgReferences
- Perepelica SA, Golubev AM, Moroz VV, et al. Causes of acute intranatal and postnatal hypoxia in neonatal infants. Obshchaya reanimatologiya. 2012;VIII(6):17–22. (In Russ.)
- Gunin AG, Milovanov MM, Denisova TG. Methods of fetal assessment in labors. Zdravoohranenie Chuvashii. 2014;3(3):9–48. (In Russ.)
- Kuznetsov PA, Kozlov PV. Fetal hypoxia and neonatal asphyxia. Lechebnoe delo. 2017;(4):9–15. (In Russ.)
- Malin GL, Morris RK, Khan KS. Strength of association between umbilical cord pH and perinatal and long term outcomes: Systematic review and meta-analysis. BMJ. 2010;340(7756):1121. doi: 10.1136/bmj.c1471
- Goodwin TM, Belai I, Hernandez P, et al. Asphyxial complications in the term newborn with severe umbilical acidemia. Am J Obstet Gynecol. 1992;167(6):1506−1512. doi: 10.1016/0002-9378(92)91728-s
- Rubak SL. Lactate measurement in umbilical cord blood in neonates. Ugeskr Laeger. 2010;172(1):364–368.
- East CE, Leader LR, Sheehan P, et al. Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fetal heart rate trace. Cochrane Database Syst Rev. 2015;(5):CD006174. doi: 10.1002/14651858.CD006174.pub3
- Wiberg-Itzel E. Determination of pH or lactate in fetal scalp blood in management of intrapartum fetal distress: randomised controlled multicenter trial. Br Med J. 2008;336:1284–1287. doi: 10.1136/bmj.39553.406991.25
- Nordström L, Achanna S, Naka K, Arulkumaran S. Fetal and maternal lactate increase during active second stage of labour. BJOG. 2001;108(3):263–268. doi: 10.1136/10.1111/j.1471-0528.2001.00034.x
- Wiberg N, Källén K. Fetal scalp blood lactate during second stage of labor: determination of reference values and impact of obstetrical interventions. J Matern Fetal Neonatal Med. 2017;30(5):612–617. doi: 10.1080/14767058.2016.1181167
- Orsonneau J-L, Fraissinet F, Sébille-Rivain V, et al. Suitability of POC lactate methods for fetal and perinatal lactate testing: considerations for accuracy, specificity and decision making criteria. Clin Chem Lab Med. 2013;51(2):397–404. doi: 10.1515/cclm-2012-0201
- Wiberg N, Klausen TW, Tyrberg T, et al. Infant outcome at four years of age after intrapartum sampling of scalp blood lactate for fetal assessment. A cohort study. PLoS One. 2018;13(3):e0193887. doi: 10.1371/journal.pone.0193887
- Remneva OV, Fadeeva NI, Fil’chakova ON, et al. Intranatal fetal hypoxia: diagnostic possibilities, reserves reducing the incidence of cerebral disorders in full-term newborns. Rossijskij vestnik pediatrii. 2015;5(5):61–66. (In Russ.)
- Pogorelova TM, Gun’ko VO, Drukker NA, Linde VA. Proteins-markers of placental insufficiency. Biomedicinskaya himiya. 2010;56(5):616–620. (In Russ.)
- Loukovaara M, Teramo K, Alfthan H, et al. Amniotic fluid S100B protein and erythropoietin in pregnancies at risk for fetal hypoxia. Eur J Obstet Gynecol Reprod Biol. 2009;142(2):115–118. doi: 10.1016/j.ejogrb.2008.10.008
- Summanen M, Seikku L, Rahkonen P, et al. Comparison of umbilical serum copeptin relative to erythropoietin and S100B as asphyxia biomarkers at birth. Neonatology. 2017;112(1):60−66. doi: 10.1159/000456063
- Irmak K, Tüten N, Karaoglu G, et al. Evaluation of cord blood creatine kinase (CK), cardiac troponin T (cTnT), N-terminal-pro-B-type natriuretic peptide (NT-proBNP), and s100B levels in nonreassuring foetal heart rate. J Matern Fetal Neonatal Med. 2021;34(8):1249−1254. doi: 10.1080/14767058.2019.1632285
- Trevisanuto D, Picco G, Golin R, et al. Cardiac troponin I in asphyxiated neonates. Biol Neonate. 2006;89(3):190–193. doi: 10.1159/000089795
- Stefanović V, Loukovaara M. Amniotic fluid cardiac troponin T in pathological pregnancies with evidence of chronic fetal hypoxia. Croat Med J. 2005;46(5):801–807.
- Joseph S, Kumar S, Ahamed MZ, Lakshmi S. Cardiac troponin-T as a marker of myocardial dysfunction in term neonates with perinatal asphyxia. Indian J Pediatr. 2018;85(10):877–84. doi: 10.1007/s12098-018-2667-3
- Asrani P, Aly AM, Jiwani AK, et al. High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus. J Perinatol. 2018;38(11):1483−1489. doi: 10.1038/s41372-018-0192-x
- Whitehead C, Teh WT, Walker SP, et al. Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status. BMC Med. 2013;11(1):1–12. doi: 10.1186/1741-7015-11-256
- Turrini I, Sorbi F, Ghizzoni V, et al. Severe fetal distress and placental damage might be associated with high troponin i (cTnI) levels in mothers. Am J Case Rep. 2018;19:194–198. doi: 10.12659/AJCR.906617
- Fleming SM, O’Gorman T, Finn J, et al. Cardiac troponin I in pre-eclampsia and gestational hypertension. BJOG. 2000;107(11):1417–1420. doi: 10.1111/j.1471-0528.2000.tb11658.x
- Joyal D, Leya F, Koh M, et al. Troponin I levels in patients with preeclampsia. Am J Med. 2007;120(9):819.e13−14. doi: 10.1016/j.amjmed.2006.05.068
- Whitehead CL, Teh WT, Walker SP, et al. Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero. PLoS One. 2013;8(11):e78487. doi: 10.1371/journal.pone.0078487
- Human reproductive and prenatal genetics. Ed. by P.C.K. Leung, J. Qiao. London: Academic Press; 2019.
- Looney AM, Walsh BH, Moloney G, et al. Downregulation of umbilical cord blood levels of mir-374a in neonatal hypoxic ischemic encephalopathy. J Pediatr. 2015;167(2):269–273. doi: 10.1016/j.jpeds.2015.04.060
- Shi J-P, Li Y-W, Sang G-M, et al. Expression and significance of serum miRNA-21 expression in neonates with HIE. Pr Prev Med. 2018;25:655–658. doi: 10.3969/j.issn.1006-3110.2018.06.005
- Ponnusamy V, Yip PK. The role of microRNAs in newborn brain development and hypoxic ischaemic encephalopathy. Neuropharmacology. 2019;149:55–65. doi: 10.1016/j.neuropharm.2018.11.041
- Tissot van Patot MC, Murray AJ, Beckey V, et al. Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioning. Am J Physiol Regul Integr Comp Physiol. 2010;298(1):R166−172. doi: 10.1152/ajpregu.00383.2009
- Nuñez A, Benavente I, Blanco D, et al. Oxidative stress in perinatal asphyxia and hypoxic-ischaemic encephalopathy. An Pediatr (Barc). 2018;88(4):228.e1−228.e9. doi: 10.1016/j.anpedi.2017.05.005
- Mitroshina EV, Abogessimengane BZH, Urazov MD, et al. Adaptive role of glial cell line-derived neurotrophic factorin cerebral ischemia. Sovremennye Tekhnologii V Medicine. 2017;9(1):68–76. (In Russ.)
- Turovsky EA, Zinchenko VP, Gaidin SG, Turovskaya MV. Calcium-binding proteins protect gabaergic neurons of the hippocampus from hypoxia and ischemia in vitro. Biol Membr. 2017;34(5):68–80. doi: 10.1134/S1990747818010105
- Coimbra-Costa D, Alva N, Duran M, et al. Oxidative stress and apoptosis after acute respiratory hypoxia and reoxygenation in rat brain. Redox Biol. 2017;12:216–25. doi: 10.1016/j.redox.2017.02.014
- Grow J, Barks JD. Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: current concepts. Clin Perinatol. 2002;29(4):585–602. doi: 10.1016/s0095-5108(02)00059-3
- Ostrova IV, Avrushchenko MS. Expression of brain-derived neurotrophic factor (BDNF) increases the resistance of neurons to death in the postresuscitation period. General Reanimatology. 2015;11(3):45−53. (In Russ.). doi: 10.15360/1813-9779-2015-3-45-53
- Ikeda T, Xia XY, Xia YX, et al. Glial cell line-derived neurotrophic factor protects against ischemia/hypoxia-induced brain injury in neonatal rat. Acta Neuropathol. 2000;100(2):161–7. doi: 10.1007/s004019900162
- Morozova AYu, Arutyunyan AV, Milyutina YuP, et al. The dynamics of the contents of neurotrophic factors in early ontogenyin the brain structures of rats subjected to prenatal hypoxia. Neurochemistry. 2018;35(3):256–263. (In Russ.). doi: 10.1134/S1027813318030081
- Morozova AYu, Arutyunyan AV, Milyutina Yu P, et al. Influence of prenatal hypoxia on the content of neuron specific enolasein the structures of the brain and blood serum of rats in early ontogeny. Neurochemistry. 2020;37(3):233–239. (In Russ.). doi: 10.31857/S1027813320030085
- Shchelchkova NA, Kokaya AA, Bezhenar’ VF, et al. The role of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in chronic fetal oxygen deprivation. Sovremennye Tekhnologii V Medicine. 2020;12(1):25–33. (In Russ.). doi: 10.17691/stm2020.12.1.03+
- Cheng H, Fu Y-S, Guo J-W. Ability of GDNF to diminish free radical production leads to protection against kainate-induced excitotoxicity in hippocampus. Hippocampus. 2004;14(1):77–86. doi: 10.1002/hipo.10145
- Shang J, Deguchi K, Yamashita T, et al. Antiapoptotic and antiautophagic effects of glial cell line-derived neurotrophic factor and hepatocyte growth factor after transient middle cerebral artery occlusion in rats. J Neurosci Res. 2010;88(10):2197–2206. doi: 10.1002/jnr.22373
- Szydlowska K, Tymianski M. Calcium, ischemia and excitotoxicity. Cell Calcium. 2010;47(2):122–129. doi: 10.1016/j.ceca.2010.01.003
- Ahn SY, Chang YS, Sung DK, et al. Pivotal role of brain-derived neurotrophic factor secreted by mesenchymal stem cells in severe intraventricular hemorrhage in newborn rats. Cell Transplant. 2017;26(1):145–156. doi: 10.3727/096368916X692861
- Feng N, Hao G, Yang F, et al. Transplantation of mesenchymal stem cells promotes the functional recovery of the central nervous system following cerebral ischemia by inhibiting myelin-associated inhibitor expression and neural apoptosis. Exp Ther Med. 2016;11(5):1595–600. doi: 10.3892/etm.2016.3089
- Mitkari B, Nitzsche F, Kerkelä E, et al. Human bone marrow mesenchymal stem/stromal cells produce efficient localization in the brain and enhanced angiogenesis after intra-arterial delivery in rats with cerebral ischemia, but this is not translated to behavioral recovery. Behav Brain Res. 2014;259:50–59. doi: 10.1016/j.bbr.2013.10.030
- Zhang R, Liu Y, Yan K, et al. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation. 2013;10:106. doi: 10.1186/1742-2094-10-106
- Lee NM, Chae SA, Lee HJ. Effects of neural stem cell media on hypoxic injury in rat hippocampal slice cultures. Brain Res. 2017;1677:20–25. doi: 10.1016/j.brainres.2017.09.018
- Liu X, Wang X, Li A, Jiao X. Effect of mesenchymal stem cell transplantation on brain-derived neurotrophic factor expression in rats with Tourette syndrome. Exp Ther Med. 2016;11(4):1211–1216. doi: 10.3892/etm.2016.3059
- Zheng Z, Zhang L, Qu Y, et al. Mesenchymal stem cells protect against hypoxia-ischemia brain damage by enhancing autophagy through brain derived neurotrophic factor/mammalin target of rapamycin signaling pathway. Stem Cells. 2018;36(7):1109–1121. doi: 10.1002/stem.2808
- Sheng S, Huang J, Ren Y, et al. Neuroprotection against hypoxic/ischemic injury: δ-opioid receptors and BDNF-TrkB pathway. Cell Physiol Biochem. 2018;47(1):302−315. doi: 10.1159/000489808
- Vedunova МV, Sakharnova ТА, Mitroshina EV, et al. Antihypoxic and neuroprotective properties of BDNF and GDNF in vitro and in vivo under hypoxic conditions. Sovremennye Tehnologii v Medicine. 2014;6(4):38–47. (In Russ.)
- Duarte EP, Curcio M, Canzoniero LM, Duarte CB. Neuroprotection by GDNF in the ischemic brain. Growth Factors. 2012;30(4):242–257. doi: 10.3109/08977194.2012.691478
- Shishkina TV. Antigipoksicheskoe i nejroprotektornoe dejstvie glial’nogo nejrotroficheskogo faktora pri modelirovanii faktorov ishemii [dissertation abstract]. Saint Petersburg; 2017 [cited 23 Aug 2021]. Available from: http://www.dslib.net/fiziologia/antigipoksicheskoe-i-nejroprotektornoe-dejstvie-glialnogo-nejrotroficheskogo.html. (In Russ.)
- Shishkina TV, Mishchenko TA, Mitroshina EV, et al. Glial cell line-derived neurotrophic factor (GDNF) counteracts hypoxic damage to hippocampal neural network function in vitro. Brain Res. 2018;1678:310–321. doi: 10.1016/j.brainres.2017.10.023
- Shhelchkova NA, Kokaja AA, Vedunova MV. Rol’ nejrotroficheskih faktorov pri gipoksii novorozhdennyh. In: VI Baltijskij kongress po detskoj nevrologii: sbornik tezisov. Ed. by V.I. Guzeva. Saint Petersburg; 2016. P. 409–410. (In Russ.)
- Golosnaya GS, Kotij SA. Vaskuloendotelial’nyj faktor rosta (VEGF) i nejrotroficheskij faktor golovnogo mozga (BDNF) u novorozhdennyh s perinatal’nymi gipoksicheskimi porazheniyami CNS. Questions of modern pediatrics. 2006;5(1):149. (In Russ.)
- Morozova AY, Milyutina YP, Kovalchuk-Kovalevskaya OV, et al. Neuron-specific enolase and brain-derived neurotrophic factor levels in umbilical cord blood in full-term newborns with intrauterine growth retardation. Journal of obstetrics and women’s diseases. 2019;68(1):29−36. (In Russ.). doi: 10.17816/JOWD68129-36
- Vedunova MV, Mishchenko TA, Mitroshina EV, Mukhina IV. TrkB-mediated neuroprotective and antihypoxic properties of brain-derived neurotrophic factor. Oxid Med Cell Longev. 2015;2015:453901. doi: 10.1155/2015/453901